| Edition |
1st ed. |
| Description |
xx, 285 p. : ill. ; 24 cm. |
| Series |
Issues in psychiatry
|
| Bibliography |
Includes bibliographical references and index. |
| Contents |
The influence of special interests, the media, and the courts on psychotropic drugs and electroconvulsive therapy: clinical trial by media: the Prozac story / Jerrold F. Rosenbaum -- Regulation of electroconvulsive therapy: the California experience / Glen N. Peterson -- Regulation of psychostimulants: how much is too much? / Robert T. Angarola, Alan G. Minsk -- Antipsychotic medication: regulation through the right to refuse / Rodney Deaton, Harold Bursztajn -- Medical marijuana / Richard B. Karel -- Cost containment: at the cost of quality and access?: The impact of cost-containment measures on somatic psychiatry / Harold I. Schwartz -- The regulating effect of the managed care movement / Edward Hanin -- Regulation of controlled substances and new drug development: law and scientific practice at the crossroads: Controlled substances, medical practice, and the law / David E. Joranson, Aaron Gilson -- The misapplication of controlled substance regulation of benzodiazepines / Harold I. Schwartz, David J. Greenblatt -- The impact of prescription drug diversion control systems and state regulations on the use of psychoactive medications / James R. Cooper, Dorynne J. Czechowicz -- The negative influence of licensing and disciplinary boards on pain treatment with controlled substances / C. Stratton Hill, Jr. -- Psychotropic drug development: the FDA and the pharmaceutical industry / Alex A. Cardoni. |
| Subject |
Biological psychiatry.
|
|
Psychiatry -- Press coverage.
|
|
Biological psychiatry -- Social aspects.
|
|
Biological psychiatry -- Government policy.
|
|
Psychotropic drugs -- Law and legislation.
|
| Added Author |
Schwartz, Harold I.
|
| ISBN |
0880484799 (acid-free) |
|
